It can be used as both injection-type or oral-type drug.[9] The marketing authorization in EU was granted on 8 February 2018.[10] It is still under review by regulatory authorities in Japan, pending approval.[11] ------------------------------------- Reported by Jules Levin AASLD 2018 Nov 9-13 SF Philip N Newsome1 ,2, Stephen A Harrison3, Sren Rasmussen4, Tea Monk Fries4, Luc Van Gaal5 1National Institute for Health Research Birmingham Biomedical Research Centre and Liver Unit at University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Conflicto de intereses Sergio Valds declara haber recibido apoyo financiero por asistencia a congresos y honorarios como ponente en actividades promovidas por Novo Nordisk y Lilly
Biochimica et Biophysica Acta (BBA) - General Subjects, 1790 (10), 11491160
Choosing the Right Path: A Personalized Decision The best choice depends on individual factors
It places semaglutide at 0.5 to 2 on a ten-point scale using a 28 to 31 gauge needle, against 2 to 4 for an intramuscular vaccine given through a 22 to 25 gauge needle
